199 related articles for article (PubMed ID: 26995558)
1. Investigation of Neurokinin-1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs.
Grobman M; Reinero C
J Vet Intern Med; 2016 May; 30(3):847-52. PubMed ID: 26995558
[TBL] [Abstract][Full Text] [Related]
2. Chronic neurokinin-1 receptor antagonism fails to ameliorate clinical signs, airway hyper-responsiveness or airway eosinophilia in an experimental model of feline asthma.
Grobman M; Graham A; Outi H; Dodam JR; Reinero CR
J Feline Med Surg; 2016 Apr; 18(4):273-9. PubMed ID: 25964466
[TBL] [Abstract][Full Text] [Related]
3. Acute neurokinin-1 receptor antagonism fails to dampen airflow limitation or airway eosinophilia in an experimental model of feline asthma.
Grobman M; Krumme S; Outi H; Dodam JR; Reinero CR
J Feline Med Surg; 2016 Feb; 18(2):176-81. PubMed ID: 25964467
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic bronchitis, eosinophilic granuloma, and eosinophilic bronchopneumopathy in 75 dogs (2006-2016).
Johnson LR; Johnson EG; Hulsebosch SE; Dear JD; Vernau W
J Vet Intern Med; 2019 Sep; 33(5):2217-2226. PubMed ID: 31468629
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage fluid lymphocytosis in 104 dogs (2006-2016).
Johnson LR; Vernau W
J Vet Intern Med; 2019 May; 33(3):1315-1321. PubMed ID: 30912207
[TBL] [Abstract][Full Text] [Related]
6. Cellular composition of bronchial brushings obtained from healthy dogs and dogs with chronic cough and cytologic composition of bronchoalveolar lavage fluid obtained from dogs with chronic cough.
Hawkins EC; Rogala AR; Large EE; Bradley JM; Grindem CB
Am J Vet Res; 2006 Jan; 67(1):160-7. PubMed ID: 16426226
[TBL] [Abstract][Full Text] [Related]
7. Canine chronic bronchitis.
Rozanski E
Vet Clin North Am Small Anim Pract; 2014 Jan; 44(1):107-16. PubMed ID: 24268336
[TBL] [Abstract][Full Text] [Related]
8. Association between cough and cytology of bronchoalveolar lavage fluid and pulmonary function in horses diagnosed with inflammatory airway disease.
Bedenice D; Mazan MR; Hoffman AM
J Vet Intern Med; 2008; 22(4):1022-8. PubMed ID: 18498325
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
Ramsey DS; Kincaid K; Watkins JA; Boucher JF; Conder GA; Eagleson JS; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):538-43. PubMed ID: 19000277
[TBL] [Abstract][Full Text] [Related]
10. Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.
Sharun K; Jambagi K; Arya M; Aakanksha ; Chaithra SN; Patel PK; Dixit SK; Dhama K
Arch Razi Inst; 2021 Nov; 76(5):1175-1182. PubMed ID: 35355772
[TBL] [Abstract][Full Text] [Related]
11. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 Nov; 245(9):1015-20. PubMed ID: 25313812
[TBL] [Abstract][Full Text] [Related]
12. Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs.
Alvillar BM; Boscan P; Mama KR; Ferreira TH; Congdon J; Twedt DC
Vet Anaesth Analg; 2012 Mar; 39(2):201-5. PubMed ID: 22103569
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.
Rau SE; Barber LG; Burgess KE
J Vet Intern Med; 2010; 24(6):1452-7. PubMed ID: 21039869
[TBL] [Abstract][Full Text] [Related]
14. Tracheobronchial brush cytology and bronchoalveolar lavage in dogs and cats with chronic cough: 45 cases (2012-2014).
Zhu BY; Johnson LR; Vernau W
J Vet Intern Med; 2015; 29(2):526-32. PubMed ID: 25818208
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.
Borrego JF; Huelsmeyer MK; Pinkerton ME; Muszynski JL; Miller SA; Kurzman ID; Vail DM
Vet Comp Oncol; 2016 Jun; 14(2):210-24. PubMed ID: 24751104
[TBL] [Abstract][Full Text] [Related]
17. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
de la Puente-Redondo VA; Siedek EM; Benchaoui HA; Tilt N; Rowan TG; Clemence RG
J Small Anim Pract; 2007 Feb; 48(2):93-8. PubMed ID: 17286662
[TBL] [Abstract][Full Text] [Related]
18. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.
Thompson AB; Daughton D; Robbins RA; Ghafouri MA; Oehlerking M; Rennard SI
Am Rev Respir Dis; 1989 Dec; 140(6):1527-37. PubMed ID: 2604284
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory action of maropitant in a mouse model of acute pancreatitis.
Tsukamoto A; Ohgoda M; Haruki N; Hori M; Inomata T
J Vet Med Sci; 2018 Mar; 80(3):492-498. PubMed ID: 29343664
[TBL] [Abstract][Full Text] [Related]
20. Interaction between maropitant and carprofen on sparing of the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs.
Fukui S; Ooyama N; Tamura J; Umar MA; Ishizuka T; Itami T; Miyoshi K; Sano T; Yamashita K
J Vet Med Sci; 2017 Mar; 79(3):502-508. PubMed ID: 28111373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
